InMode (INMD) Income from Non-Controlling Interests (2018 - 2021)
InMode (INMD) posted quarterly Income from Non-Controlling Interests of $206000.0 for Q4 2021, up 368.18% year-on-year from $44000.0 in Q4 2020, and up 300.0% on a QoQ basis from -$103000.0 in Q1 2021.
InMode (INMD) Income from Non-Controlling Interests (2018 - 2021) Analysis & Trends
InMode (INMD) has reported Income from Non-Controlling Interests for 4 consecutive years, with $206000.0 the latest figure, recorded in Q4 2021.
- Quarterly Income from Non-Controlling Interests rose 368.18% year-over-year to $206000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $103000.0 (up 1960.0% YoY) and the FY2021 annual result came in at $103000.0, up 2160.0% from the prior year.
- Income from Non-Controlling Interests grew to $206000.0 in Q4 2021 per INMD's latest filing, from -$103000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for INMD reached as high as $206000.0 in Q4 2021 and fell as low as -$103000.0 in Q1 2021.
- A 4-year average of $14272.7 and a median of $8000.0 in 2020 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2019 — Income from Non-Controlling Interests jumped 1200.0% — and 2020, when it sank 270.59%.
- Year by year, Income from Non-Controlling Interests stood at -$6000.0 in 2018, then soared by 1200.0% to $66000.0 in 2019, then sank by 33.33% to $44000.0 in 2020, then jumped by 368.18% to $206000.0 in 2021.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $206000.0, -$103000.0, and $44000.0 for Q4 2021, Q1 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | -5.85 Mn |
| 10 | InMode | 978,917.76 | -479.15 Mn | 61.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 206,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Sep 30, 2020 | 11,000.00 |
| Jun 30, 2020 | 8,000.00 |
| Mar 31, 2020 | -58,000.00 |
| Dec 31, 2019 | 66,000.00 |
| Sep 30, 2019 | -7,000.00 |
| Jun 30, 2019 | -38,000.00 |
| Mar 31, 2019 | 34,000.00 |
| Dec 31, 2018 | -6,000.00 |